Changchun Dirui Pharmaceutical Co., Ltd.
-
Founded in:
1998-08-04 -
Country:
China -
Address:
No. 639, Maoxiang Street, Changchun High-tech Industrial Development Zone -
Tax NO.:
912201017025392978 -
Registered Funds:
45 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfadiazine |
Acts on dihydrofolate synthase, interfering with the first step of folic acid synthesis, and has a synergistic antibacterial effect when used in combination with trimethoprim
More
Acts on dihydrofolate synthase, interfering with the first step of folic acid synthesis, and has a synergistic antibacterial effect when used in combination with trimethoprim |
0.19~0.21g | 68-35-9 | 14 |
| Trimethoprim |
It acts on the second step of folic acid anabolism, selectively inhibits the action of dihydrofolate reductase, and has a synergistic antibacterial effect when used in combination with sulfadiazine
More
It acts on the second step of folic acid anabolism, selectively inhibits the action of dihydrofolate reductase, and has a synergistic antibacterial effect when used in combination with sulfadiazine |
22.5~27.5mg | 738-70-5 | 44 |
| Sodium bicarbonate |
Alkalinize urine to reduce the possibility of urinary crystallization of sulfonamides
More
Alkalinize urine to reduce the possibility of urinary crystallization of sulfonamides |
0.1425~0.1575g | 144-55-8 | 47 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfadiazine |
Acts on dihydrofolate synthase, interfering with the first step of folic acid synthesis; combined with trimethoprim, it has a synergistic antibacterial effect
More
Acts on dihydrofolate synthase, interfering with the first step of folic acid synthesis; combined with trimethoprim, it has a synergistic antibacterial effect |
0.19～0.21g | 68-35-9 | 14 |
| Trimethoprim |
It selectively inhibits the action of dihydrofolate reductase and has a synergistic antibacterial effect against a variety of bacteria when used in combination with sulfadiazine
More
It selectively inhibits the action of dihydrofolate reductase and has a synergistic antibacterial effect against a variety of bacteria when used in combination with sulfadiazine |
22.5～27.5mg | 738-70-5 | 44 |
| Sodium bicarbonate |
Alkalinize urine to reduce the possibility of urinary crystallization of sulfonamides
More
Alkalinize urine to reduce the possibility of urinary crystallization of sulfonamides |
0.1425～0.1575g | 144-55-8 | 47 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cimetidine |
It can significantly inhibit the basal gastric acid secretion during the day and night, and can also inhibit the gastric acid secretion induced by food, histamine, pentagastrin, caffeine and insulin.
More
It can significantly inhibit the basal gastric acid secretion during the day and night, and can also inhibit the gastric acid secretion induced by food, histamine, pentagastrin, caffeine and insulin. |
51481-61-9 | 35 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Allantoin |
It has a weak local anesthetic effect, can reduce the irritation of irritants, stimulate epithelial proliferation, and promote wound healing.
More
It has a weak local anesthetic effect, can reduce the irritation of irritants, stimulate epithelial proliferation, and promote wound healing. |
1mg | 97-59-6 | 6 |
| Zinc sulphate |
It has astringent and bactericidal effects. It has astringent effects at low concentrations (below 3%) and can form a protein film with proteins in inflammatory tissues or secretions, causing capillaries to contract and relieve local congestion.
More
It has astringent and bactericidal effects. It has astringent effects at low concentrations (below 3%) and can form a protein film with proteins in inflammatory tissues or secretions, causing capillaries to contract and relieve local congestion. |
1mg | 7733-02-0 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gentamicin |
This product is a broad-spectrum aminoglycoside antibiotic, and its mechanism of action is mainly to inhibit bacterial protein synthesis. It has antibacterial effects on common Gram-negative bacteria in the eye.
More
This product is a broad-spectrum aminoglycoside antibiotic, and its mechanism of action is mainly to inhibit bacterial protein synthesis. It has antibacterial effects on common Gram-negative bacteria in the eye. |
1403-66-3 | 2 |